Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery

NCT: NCT07591610 · NOT_YET_RECRUITING

NCT IDNCT07591610
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2029-10-31

Brief Summary

The aim of the study is to assess whether perioperative use of high-flow nasal oxygen (HFNO) during the period from induction of anesthesia until discharge from the post-anesthesia care unit in patients undergoing robotic-assisted surgery reduces perioperative oxygen desaturation and postoperative pulmonary complications.

Frequently Asked Questions

What is Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery?

Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery is a clinical trial registered under NCT07591610. Current status: NOT_YET_RECRUITING.

What is the status of NCT07591610?

The current status of NCT07591610 (Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery) is: NOT_YET_RECRUITING.

When did Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery start?

Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑